Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
Schatz, Jonathan H.
Wolfe, Andrew L.
Rajasekhar, Vinagolu K.
Pagano, Nen C.
Porco, John A.
Zelenetz, Andrew D.
MetadataShow full item record
CitationJonathan H Schatz, Elisa Oricchio, Andrew L Wolfe, Man Jiang, Irina Linkov, Jocelyn Maragulia, Weiji Shi, Zhigang Zhang, Vinagolu K Rajasekhar, Nen C Pagano, John A Porco, Julie Teruya-Feldstein, Neal Rosen, Andrew D Zelenetz, Jerry Pelletier, Hans-Guido Wendel. 2011. "Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.." J Exp Med, Volume 208, Issue 9, pp. 1799 - 1807.
New anticancer drugs that target oncogenic signaling molecules have greatly improved the treatment of certain cancers. However, resistance to targeted therapeutics is a major clinical problem and the redundancy of oncogenic signaling pathways provides back-up mechanisms that allow cancer cells to escape. For example, the AKT and PIM kinases produce parallel oncogenic signals and share many molecular targets, including activators of cap-dependent translation. Here, we show that PIM kinase expression can affect the clinical outcome of lymphoma chemotherapy. We observe the same in animal lymphoma models. Whereas chemoresistance caused by AKT is readily reversed with rapamycin, PIM-mediated resistance is refractory to mTORC1 inhibition. However, both PIM- and AKT-expressing lymphomas depend on cap-dependent translation, and genetic or pharmacological blockade of the translation initiation complex is highly effective against these tumors. The therapeutic effect of blocking cap-dependent translation is mediated, at least in part, by decreased production of short-lived oncoproteins including c-MYC, Cyclin D1, MCL1, and the PIM1/2 kinases themselves. Hence, targeting the convergence of oncogenic survival signals on translation initiation is an effective alternative to combinations of kinase inhibitors.
RightsCreative Commons License Attribution–Noncommercial–Share Alike 3.0 Unported
Showing items related by title, author, creator and subject.
Xu, Xiaobin (2014)This dissertation is focused on developing cross-linking and mass spectrometry methodologies to study protein-protein interactions. Top-down cross-linking, in combination with mass spectrometry, provides advantages over ...
Inhibition of Dynamin-Dependent Endocytosis Increases Shedding of the Amyloid Precursor Protein Ectodomain and Reduces Generation Of Amyloid β Protein Carey, Robyn M.; Balcz, Brigitte A.; Lopez-Coviella, Ignacio; Slack, Barbara E. (BioMed Central, 2005-8-11)BACKGROUND. The amyloid precursor protein (APP) is transported via the secretory pathway to the cell surface, where it may be cleaved within its ectodomain by α-secretase, or internalized within clathrin-coated vesicles. ...
Oxysterol-Binding Protein-1 (OSBP1) Modulates Processing and Trafficking of the Amyloid Precursor Protein Zerbinatti, Celina V.; Cordy, Joanna M.; Chen, Ci-Di; Guillily, Maria; Suon, Sokreine; Ray, William J.; Seabrook, Guy R.; Abraham, Carmela R.; Wolozin, Benjamin (BioMed Central, 2008-3-18)BACKGROUND Evidence from biochemical, epidemiological and genetic findings indicates that cholesterol levels are linked to amyloid-β (Aβ) production and Alzheimer's disease (AD). Oxysterols, which are cholesterol-derived ...